Categories: News

NYSE Content Advisory: Pre-Market update + McGraw Hill, Accelerant IPO on NYSE

NEW YORK, July 24, 2025 /PRNewswire/ — The New York Stock Exchange (NYSE) provides a daily pre-market update directly from the NYSE Trading Floor. Access today’s NYSE Pre-market update for market insights before trading begins.

- Advertisement -

Ashley Mastronardi delivers the pre-market update on July 24th

- Advertisement -
  • Stocks are mixed Thursday morning following the S&P 500’s 12th record close of the year on Wednesday. The index received a boost Tuesday night when President Trump announced a trade deal with Japan.
  • The NYSE was in attendance at the All In’s AI Summit and before President Trump gave his closing keynote, spoke to leaders on a cross-section of topics including AI, energy, robotics, infrastructure, and legislation
  • Education solutions firm McGraw Hill, which raised nearly $415 million in its IPO will debut on the NYSE today. Specialty risk company Accelerant, which raised over $723 million, will debut as well.
  • The New York Stock Exchange announced this morning that NYSE Texas has listed its first exchange traded funds, with Strive Asset Management dual-listing 13 ETFs

Opening Bell
McGraw Hill celebrates its IPO on the New York Stock Exchange

- Advertisement -

Closing Bell
The Autism Science Foundation and Wall Street Rides FAR celebrate the 11th season of Rides FAR and its support for innovative autism research.

- Advertisement -

Click here to download the NYSE TV App

- Advertisement -

 

- Advertisement -

Video – https://mma.prnewswire.com/media/2737653/NYSE_Market_Update_July_24.mp4

- Advertisement -

Logo – https://mma.prnewswire.com/media/2581322/New_York_Stock_Exchange_Logo.jpg

- Advertisement -

View original content:https://www.prnewswire.co.uk/news-releases/nyse-content-advisory-pre-market-update–mcgraw-hill-accelerant-ipo-on-nyse-302513148.html

- Advertisement -

Recent Posts

Deepak Group Goes Beyond Green with hands-On Mangrove Restoration

Deepak Group undertakes mangrove plantation drive on World Environment DaySustainable restoration along the Paniyadra coast,…

5 seconds ago

Biomea Fusion Presents New Clinical and Translational Data for Icovamenib at the American Diabetes Association (ADA) 86th Scientific Sessions and Announces Expansion of Ongoing Phase I BMF-650 Study

•Translational data presented at ADA demonstrate icovamenib’s potential to promote muscle preservation and fat reduction,…

4 hours ago

Hengrui Pharma and Kailera Therapeutics Present Ribupatide Clinical Data at ADA 2026

Presentations will feature clinical results for ribupatide, a GLP-1/GIP receptor dual agonist being developed as…

4 hours ago

Cullinan Therapeutics Presents Initial Clinical Data for CLN-978, a CD19xCD3 T Cell Engager, at the EULAR 2026 Congress

Clinical benefit, including remissions, demonstrated in both systemic lupus erythematosus (SLE) and rheumatoid arthritis (RA)…

4 hours ago

Bluejay Diagnostics Announces Closing of Up to $23.7 Million Private Placement Priced At-The-Market Under Nasdaq Rules

June 05, 2026 20:13 ET  | Source: Bluejay Diagnostics, Inc. $8.5 million upfront with up…

4 hours ago